ECSP003633A - PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR - Google Patents
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FORInfo
- Publication number
- ECSP003633A ECSP003633A ECSP003633A ECSP003633A EC SP003633 A ECSP003633 A EC SP003633A EC SP003633 A ECSP003633 A EC SP003633A EC SP003633 A ECSP003633 A EC SP003633A
- Authority
- EC
- Ecuador
- Prior art keywords
- partially
- situ
- solubility
- hydro
- procedure
- Prior art date
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960004380 tramadol Drugs 0.000 title abstract 2
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title abstract 2
- 239000002131 composite material Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a formas farmacéuticas oral al menos particularmente retardadas cuya sustancia activa farmacéutica tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad <= 100mg/ml, y procedimiento para su preparación.The invention relates to at least particularly delayed oral dosage forms whose pharmaceutical active ingredient tramadol is at least partially in the form of a compound formed in situ with a water solubility <= 100mg / ml, and method for their preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003633 ECSP003633A (en) | 2000-08-24 | 2000-08-24 | PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003633 ECSP003633A (en) | 2000-08-24 | 2000-08-24 | PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003633A true ECSP003633A (en) | 2000-12-19 |
Family
ID=42041237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003633 ECSP003633A (en) | 2000-08-24 | 2000-08-24 | PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003633A (en) |
-
2000
- 2000-08-24 EC ECSP003633 patent/ECSP003633A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR025427A1 (en) | PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN FORM OF A DEPOSIT FORMED IN SITU WITH A HYDROSOLUBILITY <O = 100 MG / ML, AND PROCEDURE FOR PREPARATION | |
| IT1276689B1 (en) | SOLID PHARMACEUTICAL FORM FOR ORAL USE | |
| AR037490A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES | |
| CO5011053A1 (en) | PROCEDURE FOR THE PRODUCTION OF A SOLID DOSAGE FORM CONTAINING CARVEDILOL AND HYDROCLOROTIAZIDA AND PHARMACEUTICAL FORMS OBTAINED BY SUCH PROCEDURE | |
| CA2301378A1 (en) | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin | |
| EA200000245A1 (en) | QUICKLY DISINTEGRATING METAL CELLULOSE TABLETS | |
| WO2003105800A3 (en) | GALENIC FORM, IN THE FORM OF A FILM ADHERING TO THE MUCOSA, FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OF CANNABIS | |
| AR080436A2 (en) | SOLID PREPARATION FOR QUICK DISINTEGRATION, USE OF A LITTLE HYDROXYPROPILCELULOSE IN SUCH PREPARATION AND METHOD TO IMPROVE THE ORAL DISINTEGRABILITY OF THE SAME | |
| NO20023551D0 (en) | Ibuprofen-containing active agent preparation | |
| CO5280073A1 (en) | COMPOSITIONS | |
| ATE541562T1 (en) | IBUPROFEN SUSPENSION | |
| WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
| ECSP034826A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE | |
| EA200000487A1 (en) | COMPOSITION OF PROLONGED SHIPPING | |
| BR0111868A (en) | Pharmaceutical Compositions | |
| ES2191987T3 (en) | DOSAGE FORMS OF RIBAVIRINA SOLIDAS, ADMINISTRABLE ORALALLY, AND MANUFACTURING PROCEDURE. | |
| RU2003100507A (en) | PHARMACEUTICAL COMPOSITIONS | |
| ATE262893T1 (en) | DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| AR036085A1 (en) | DOSAGE FORMS AND PROCEDURE FOR MANUFACTURING | |
| WO2001080619A3 (en) | Pharmaceutical composition containing citalopram | |
| BR0116060A (en) | Dronedarone pharmaceutical composition for parenteral administration | |
| WO2002015933A3 (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
| WO2004071156A3 (en) | Use of edible acid in fast-dispersing pharmaceutical solid dosage forms | |
| WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
| ECSP003633A (en) | PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR |